Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24

Bulletin Express

02/10

Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.

According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.

Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1166255992"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1166255992\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1166255992?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 23:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166255992","market":"us","top_or_hot":-1,"title":"Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24","media":"Bulletin Express","content":"<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarcoin Group Limited (399) Requests Review of Listing Committee Decision on Rule 13.24\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-02-10 23:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.</p>\n<p>According to the latest disclosure, after the Listing Committee’s verdict (the “LC Decision”), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.</p>\n<p>Relevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00399","symbol_name":"星太鏈集團","start_time":0,"source_url":"","article_id":"1166255992","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166255992","pubTimestamp":1770738163,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00399":"星太链集团"},"translate_title":"星币集团有限公司(399)要求覆核上市委员会根据第13.24条作出的决定","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00399":1},"content_text":"Starcoin Group Limited (formerly known as Innovative Pharmaceutical Biotech Limited), Stock Code 399, announced that the Stock Exchange of Hong Kong has determined the company did not maintain a sufficient level of operations as required under Rule 13.24 of the Listing Rules. Previous announcements dated 17 November 2025, 24 November 2025, and 2 February 2026 disclosed the decision by the Stock Exchange and the subsequent review application filed with the Listing Committee.\nAccording to the latest disclosure, after the Listing Committee’s verdict (the 「LC Decision」), a written request was submitted on 10 February 2026 to refer the matter to the Listing Review Committee. The outcome of this review remains uncertain.\nRelevant stakeholders are advised to stay alert to further developments and exercise caution when dealing in the company’s securities. The board also stated it will make additional announcements if necessary under the Listing Rules.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}